These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38773976)

  • 1. Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.
    Wang JB; Gao YX; Ye YH; Zheng QL; Luo HY; Wang SH; Zhang T; Jin QW; Zheng CH; Li P; Lin JX; Chen QY; Cao LL; Yang YH; Huang CM; Xie JW
    Theranostics; 2024; 14(7):2915-2933. PubMed ID: 38773976
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.
    Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W
    Front Immunol; 2024; 15():1377472. PubMed ID: 38807601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a TAN-associated risk score model with integrated multi-omics data analysis and clinical validation in gastric cancer.
    Xu Z; Zhang L; Wang X; Pan B; Zhu M; Wang T; Xu W; Li L; Wei Y; Wu J; Zhou X
    Life Sci; 2024 Jul; 349():122731. PubMed ID: 38782354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of immunotherapy-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognostic signature in gastric carcinoma.
    Li J; Han T; Yang J; Wang X; Wang Y; Yang R; Yang Q
    Aging (Albany NY); 2024 Jun; 16(14):11185-11207. PubMed ID: 39074262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy.
    Huang K; Lin Y; Qiu G; Wang S; Feng L; Zheng Z; Gao Y; Fan X; Zheng W; Zhuang J; Luo F; Feng S
    Aging (Albany NY); 2023 Aug; 15(16):8113-8136. PubMed ID: 37595258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer.
    Wang JB; Qiu QZ; Zheng QL; Zhao YJ; Xu Y; Zhang T; Wang SH; Wang Q; Jin QW; Ye YH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Yang YH; Zheng CH; Huang CM
    Adv Sci (Weinh); 2023 May; 10(15):e2207417. PubMed ID: 36998102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis Patterns Characterized by Distinct Tumor Microenvironment Infiltration Landscapes in Gastric Cancer.
    Xiang R; Ge Y; Song W; Ren J; Kong C; Fu T
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
    Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
    Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.
    Gong Z; Zhang J; Guo W
    Cancer Med; 2020 Dec; 9(23):9052-9063. PubMed ID: 33030278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer.
    Peng B; Lin Y; Yi G; Lin M; Xiao Y; Qiu Y; Yao W; Zhou X; Liu Z
    Sci Rep; 2024 Jul; 14(1):16404. PubMed ID: 39013954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between the modification patterns mediated by pyroptosis-related genes, tumor microenvironment, and immunotherapy in soft tissue sarcoma.
    Cai Y; Meng J; Qiu Y; Huang X; Du H; Yao J
    Medicine (Baltimore); 2024 May; 103(20):e38173. PubMed ID: 38758862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing.
    Ding C; Yang X; Li S; Zhang E; Fan X; Huang L; He Z; Sun J; Ma J; Zang L; Zheng M
    Cancer Cell Int; 2023 May; 23(1):95. PubMed ID: 37198617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
    Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
    Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
    Zhao Y; Li D; Zhuang J; Li Z; Xia Q; Li Z; Yu J; Wang J; Zhang Y; Li K; Xu S; Li S; Ma P; Cao Y; Liu C; Xu C; Liu Z; Wei J; Zhang C; Qiao L; Gao X; Hou Z; Liu C; Zheng R; Wang D; Liu Y
    Clin Transl Med; 2024 May; 14(5):e1674. PubMed ID: 38685486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data.
    Liu Y; Bie F; Bai G; Huai Q; Li Y; Chen X; Zhou B; Gao S
    Clin Transl Oncol; 2024 Aug; 26(8):2025-2036. PubMed ID: 38563846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.
    Zhao W; Liang Z; Yao Y; Ge Y; An G; Duan L; Yao J
    Cancer Immunol Immunother; 2024 May; 73(7):131. PubMed ID: 38748299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis.
    Cai X; Yang J; Guo Y; Yu Y; Zheng C; Dai X
    J Transl Med; 2024 Aug; 22(1):807. PubMed ID: 39215354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.